Novartis AGNVSNYSE
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank64
5Y CAGR+30.2%
Studio
Year-over-Year Change

Year-over-year gross profit growth rate

5Y CAGR
+30.2%/yr
Long-term compound
Percentile
P64
Within normal range
vs 5Y Ago
3.7x
Strong expansion
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
20255.72%
202413.77%
20237.24%
2022-1.12%
2021-7.30%
20201.53%
20198.43%
20186.11%
2017-6.72%
2016-3.23%